Acutus Medical Inc.'s next confirmed earnings release is scheduled for November 16, 2026.
| Earnings Date | 11/16/2026 |
As of December 31, 2024, Acutus Medical Inc. has 29.91M shares outstanding.
| Shares Outstanding | 29.91M |
As of December 31, 2024, Acutus Medical Inc. maintains a current ratio of 2.06, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -308.52, indicating conservative leverage, while an interest coverage ratio of 0.17 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.06 |
| Quick Ratio | 1.76 |
| Debt / Equity | -308.52 |
| Debt / EBITDA | 37.22 |
| Interest Coverage | 0.17 |
These figures cover the twelve months ended December 31, 2024. Return on assets (ROA) is negative at -23.11, reflecting losses generated across the asset base. The company generates approximately 102,795.92 in revenue per employee across its workforce of 196.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.31 indicates how many times Acutus Medical Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -23.11 |
| Revenue Per Employee | 102,795.92 |
| Employee Count | 196.00 |
| Inventory Turnover | 6.31 |
As of the close on November 12, 2026, Acutus Medical Inc.'s stock has declined approximately 80.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| 52-Week Price Change | -80.00% |
Over the twelve months ended December 31, 2024, Acutus Medical Inc. generated 20.15M in revenue and converted that into -9.55M in net income, yielding earnings per share of -0.15. EBITDA reached 961,000.00, while operating income came in at -9.43M.
| Revenue | 20.15M |
| Gross Profit | 1.00M |
| Operating Income | -9.43M |
| Pretax Income | -4.54M |
| Net Income | -9.55M |
| EBITDA | 961,000.00 |
| EBIT | -66,000.00 |
| Earnings Per Share (EPS) | -0.15 |
As of December 31, 2024, Acutus Medical Inc. holds 14.02M in cash and equivalents against 35.76M in total debt, resulting in a net debt position of 18.55M. Total book value stands at -11.59M, with working capital of 13.14M providing operational flexibility.
| Cash & Cash Equivalents | 14.02M |
| Total Debt | 35.76M |
| Net Debt | 18.55M |
| Equity (Book Value) | -11.59M |
| Book Value Per Share | -0.39 |
| Working Capital | 13.14M |
Acutus Medical Inc. produced -31.66M in operating cash flow over the twelve months ended December 31, 2024. After subtracting -112,000.00 in capital expenditures, free cash flow totaled -31.77M - equivalent to -1.07 per share.
| Operating Cash Flow | -31.66M |
| Capital Expenditures | -112,000.00 |
| Free Cash Flow | -31.77M |
| FCF Per Share | -1.07 |
Over the twelve months ended December 31, 2024, Acutus Medical Inc. posted a gross margin of 4.98, reflecting its pricing power and cost economics. The operating margin of -46.81 and net profit margin of -47.38 provide insight into operational efficiency.
| Gross Margin | 4.98 |
| Operating Margin | -46.81 |
| Pretax Margin | -22.55 |
| Profit Margin | -47.38 |
| EBITDA Margin | 4.77 |